Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses
Noroviruses can cause gastroenteritis and there is currently no licensed vaccine or specific treatment available. Here, the authors isolate human monoclonal antibodies and characterize one antibody (NORO-320) with broad reactivity to genogroup I and II noroviruses.
Guardado en:
Autores principales: | Gabriela Alvarado, Wilhelm Salmen, Khalil Ettayebi, Liya Hu, Banumathi Sankaran, Mary K. Estes, B. V. Venkataram Prasad, James E. Crowe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/33925668740440828a0fc9a2f93f6e1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms
por: Abimbola O. Kolawole, et al.
Publicado: (2017) -
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics
por: Zhizeng Sun, et al.
Publicado: (2018) -
Genogrouping of Infectious Bursal Disease Viruses Circulating in Ethiopian Chickens: Proposal for Assigning Very Virulent Strains in the Country into New Sub Genogroup 3d
por: Bari FD
Publicado: (2021) -
Glycan recognition in globally dominant human rotaviruses
por: Liya Hu, et al.
Publicado: (2018) -
Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies
por: Rachael Keating, et al.
Publicado: (2020)